Pustular psoriasis affects around 3% of people with psoriasis — making it rare but clinically significant. Its defining feature is pus-filled blisters that appear on the skin, either in localized areas or across much of the body. The pus is sterile — it is caused by an accumulation of white blood cells driven by inflammation, not by bacteria or infection. This is one of the most important things to understand about pustular psoriasis: the pustules look like an infection but are not contagious and cannot be spread. The three distinct subtypes of pustular psoriasis have very different presentations, urgency levels, and treatment approaches — knowing which type is present is the most important factor in managing it correctly.
The Three Types of Pustular Psoriasis
Generalized Pustular Psoriasis (GPP)
Medical Emergency — Seek Care ImmediatelyGPP is the most serious form of pustular psoriasis. Pustules erupt suddenly across large areas of the body — often covering widespread skin simultaneously — accompanied by systemic symptoms: high fever, chills, rapid heartbeat, fatigue, muscle weakness, and severe itch or skin pain. The skin between pustules is typically bright red and inflamed. After the pustules burst, they leave raw, glazed skin that is acutely painful and highly susceptible to infection.
GPP disrupts the body's temperature regulation and fluid balance in the same way as erythrodermic psoriasis. It is potentially life-threatening and requires immediate medical care — hospitalization is frequently necessary to stabilize the patient before treating the psoriasis. About 54% of people with GPP also have plaque psoriasis. GPP is more common in women than men, and can be triggered during pregnancy (third trimester), when it is sometimes called pustular psoriasis of pregnancy.
Key triggers: Sudden withdrawal from systemic corticosteroids or other psoriasis medications, infections (particularly strep), emotional stress, and certain drugs including antimalarials and antibiotics.
Palmoplantar Pustular Psoriasis (PPPP)
Chronic — Dermatology ReferralPPPP is localized to the palms of the hands and soles of the feet. It causes clusters of sterile yellow or white pustules on a background of red, inflamed skin. The pustules cycle — they appear, fill with pus, turn brown as they dry, then crust and peel — before new pustules form. This cycle typically repeats every few weeks. Between cycles the skin may crack and scale. Walking and hand use are painful during active flare phases.
PPPP affects far more women than men (approximately 3.5 times more common in women) and is strongly associated with smoking — around 80% of people with PPPP are current or past smokers. It can coexist with plaque psoriasis but frequently occurs without other psoriasis involvement elsewhere on the body. PPPP is the same condition sometimes referred to as palmoplantar pustulosis in the comparison article linked below.
Key triggers: Tobacco use, stress, infections, certain medications, and skin trauma to the hands and feet.
Acrodermatitis Continua of Hallopeau (ACH)
Rare — Specialist ReferralACH is the rarest subtype of pustular psoriasis. It affects only the tips of the fingers and toes — particularly around and under the nails. Pustules form at the fingertip or toenail area, causing the surrounding skin to become red, inflamed, and scaly. Over time, without treatment, ACH can cause significant nail destruction and, in some cases, bone resorption (loss of the terminal bone in the digit). It can develop spontaneously or following injury or infection at the fingertip.
Because of its rarity and the potential for irreversible digit damage, ACH requires prompt specialist assessment and ongoing management. Early diagnosis significantly improves outcome.
Key triggers: Trauma to the fingers or toes, infections at the fingertip, and in some cases spontaneous onset without a clear precipitating event.
Go to the emergency room immediately if you experience:
- Pus-filled blisters appearing suddenly across widespread skin areas
- Fever, chills, or rapid heartbeat alongside widespread pustules
- Skin that looks raw and glazed after pustules burst across large areas
- Severe weakness, muscle pain, or difficulty maintaining normal body temperature
- Known GPP with a sudden and severe new flare
Causes and Triggers
All three subtypes of pustular psoriasis involve an overactive immune response, but the specific molecular pathways differ from those driving plaque psoriasis — which is why some treatments effective for plaque psoriasis may not work for pustular subtypes and vice versa. GPP in particular has been linked to mutations in the IL36RN gene, which leads to unregulated production of inflammatory cytokines in the skin. This genetic basis explains why GPP can occur in people with no other psoriasis history and why it can present in children as well as adults.
The triggers most consistently documented across pustular subtypes are abrupt withdrawal from systemic corticosteroids or biologic treatment, infections — streptococcal and staphylococcal bacteria in particular — certain medications including antimalarials and lithium, and significant emotional or physical stress. For PPPP specifically, tobacco use is the dominant modifiable trigger.
| Feature | GPP | PPPP | ACH |
|---|---|---|---|
| Location | Widespread — most of body | Palms and soles only | Fingertips and toenails only |
| Urgency | Medical emergency | Chronic — dermatology | Chronic — specialist |
| Systemic symptoms | Fever, chills, rapid heartbeat | None beyond local pain | None beyond local inflammation |
| Who gets it | Adults and children; women slightly more | Middle-aged women; 80% smokers | Adults; rare in children |
| Nail involvement | Can occur in severe GPP | Possible nail changes | Central feature — nail destruction risk |
| Key trigger | Medication withdrawal, infection | Tobacco, stress, infection | Trauma to fingertips, infection |
Treatment by Subtype
GPP — acute management
Hospital admission is typically required for acute GPP to stabilize temperature and fluid balance. Once the patient is medically stable, systemic treatment is initiated rapidly. Spesolimab (Spevigo) — an IL-36 receptor inhibitor — is the only FDA-approved treatment specifically indicated for GPP flares in adults. It works by blocking the IL-36 pathway that drives the acute inflammatory cascade in GPP. Infliximab (an IV biologic) can also reduce inflammation quickly in acute GPP. Acitretin, cyclosporine, and methotrexate are traditional systemic options used when newer biologics are not available or appropriate.
After the acute flare resolves, ongoing maintenance treatment is typically needed to prevent recurrence. The treatment plan for maintenance is reassessed carefully — abrupt discontinuation of treatment is itself a major GPP trigger, so transitions between treatments must be managed gradually and with dermatologist oversight.
PPPP — chronic management
Smoking cessation is the single most impactful intervention for PPPP — the 80% smoking prevalence and the documented reduction in pustule cycle frequency after quitting make this a clinical priority, not a lifestyle preference. Topical corticosteroids under occlusion are a standard first-line approach, often combined with topical vitamin D analogues. PUVA phototherapy — psoralen plus UVA — is frequently used for PPPP when topicals are insufficient, and is more commonly indicated than narrowband UVB for this specific subtype. Acitretin (an oral retinoid) is often prescribed for moderate to severe PPPP. Biologics are reserved for cases that do not respond to standard approaches.
ACH — preventing progression
Early treatment of ACH is critical to prevent the irreversible nail and digit damage that can result from prolonged uncontrolled disease. Potent topical corticosteroids and topical vitamin D analogues are first-line. Systemic retinoids are often effective for ACH. Biologics — particularly IL-17 inhibitors — have shown efficacy in resistant ACH. Because of the rarity and severity of potential digit complications, ACH should be managed by a specialist with experience in this condition.
Abrupt withdrawal from systemic corticosteroids, methotrexate, or biologics is one of the most documented triggers for all types of pustular psoriasis — and particularly for GPP. Never stop these medications suddenly without guidance from your dermatologist. If you need to discontinue a treatment for any reason, a tapering plan or a bridge to an alternative treatment is essential to prevent a severe rebound flare.
Pustular Psoriasis vs. Other Conditions
Pustular psoriasis is most commonly confused with bacterial skin infections (impetigo, folliculitis), contact dermatitis with vesiculation, and — for PPPP specifically — palmoplantar psoriasis with secondary blistering. The key clinical fact is that pustular psoriasis pustules are sterile: bacterial cultures are negative. A dermatologist will typically take a swab to confirm sterility and rule out infection, and may biopsy the skin in unclear cases. Treatment with antibiotics will not affect pustular psoriasis, while antipsoriatic treatment will not affect a true infection — getting the diagnosis right before treating is the critical step.
Related reading:
Nopsor — Steroid-Free Psoriasis Relief
Coal tar, salicylic acid, and 8 medicinal herbs for stable psoriasis management. For acute GPP flares, seek emergency medical care immediately.
See the Nopsor Treatment Set →40-day money-back guarantee for purchases at nopsor-usa.com or Amazon · No prescription needed
References
- National Psoriasis Foundation. Pustular psoriasis: Symptoms, causes and treatment. psoriasis.org
- National Psoriasis Foundation. Generalized pustular psoriasis. psoriasis.org
- American Academy of Dermatology. Pustular psoriasis: Treatment. aad.org
- American Academy of Dermatology. Psoriasis: Signs and symptoms. aad.org
